Caleb Taylor scored a 90th-minute winner as Wycombe defeated Stevenage 1-0 at Adams Park to keep their hopes of automatic ...

DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

Stocks recovered from a mid-morning swoon Friday as short covering emerged after the Financial Times reported that Boston Fed President Collins said the Fed “would absolutely be prepared” to help ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...

S&P 500 E-Mini futures are trending up +0.69% this morning as investors await crucial U.S. producer inflation data and earnings reports from some of the biggest U.S. banks. U ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

DexCom, Inc. , the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the ...

Analysis of OSHA data finds lack of training and failure to follow basic safety protocols are to blame for most ...

Trump stunned business leaders on both sides of the Atlantic when he unveiled a range of sweeping new tariffs on dozens of ...